Stephen Smolinski

Insider Reports History

Entity
Individual
Location
C/O Selecta Biosciences, Inc., 480 Arsenal Way, Watertown, MA
Signature
/s/ Christopher Sullivan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Smolinski:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Avalo Therapeutics, Inc. Chief Commercial Officer Stock Option (Right to Buy) 400K Jan 4, 2022 Direct

Insider Reports Filed by Stephen Smolinski

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVTX Avalo Therapeutics, Inc. Jan 4, 2022 1 $0 4 Jan 6, 2022 Chief Commercial Officer
AVTX Avalo Therapeutics, Inc. Jan 3, 2022 0 $0 3 Jan 6, 2022 Chief Commercial Officer